The estimated Net Worth of Adele C Oliva is at least $2.39 Million dollars as of 8 November 2019. Ms. Oliva owns over 153,846 units of TELA Bio stock worth over $2,346,073 and over the last 5 years she sold TELA stock worth over $0. In addition, she makes $43,395 as Independent Director at TELA Bio.
Adele has made over 1 trades of the TELA Bio stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 153,846 units of TELA stock worth $1,999,998 on 8 November 2019.
The largest trade she's ever made was buying 153,846 units of TELA Bio stock on 8 November 2019 worth over $1,999,998. On average, Adele trades about 76,923 units every 0 days since 2019. As of 8 November 2019 she still owns at least 888,664 units of TELA Bio stock.
You can see the complete history of Ms. Oliva stock trades at the bottom of the page.
Adele C. Oliva serves as Independent Director of the Company. Adele Oliva has been a member of our Board since 2012. Ms. Oliva co-founded 1315 Capital, a firm focused on health care growth investing, in 2014. Since 2007, Ms. Oliva has served as a partner of Quaker Partners, a healthcare investment firm. Prior to joining Quaker Partners, she was Co-Head of US Healthcare at Apax Partners, a global private equity firm. Ms. Oliva serves as a member of the board of directors of Colorescience, Innovative Health, Sprout Pharmaceuticals, Greenbrook TMS Inc. and Onkos Surgical. She received a Bachelor of Science degree from St. Joseph’s University and a Masters of Business Administration from Cornell University, where she was awarded the Albert Fried fellowship.
As the Independent Director of TELA Bio, the total compensation of Adele Oliva at TELA Bio is $43,395. There are 8 executives at TELA Bio getting paid more, with Antony Koblish having the highest compensation of $2,399,600.
Adele Oliva is 53, she's been the Independent Director of TELA Bio since 2012. There are 8 older and 5 younger executives at TELA Bio. The oldest executive at TELA Bio, Inc. is Maarten Persenaire, 63, who is the Co-Founder, Chief Medical Officer.
Adele's mailing address filed with the SEC is C/O QUAKER BIOVENTURES CAPITAL II, L.P., 150 MONUMENT ROAD, SUITE 207, BALA CYNWYD, PA, 19004.
Over the last 5 years, insiders at TELA Bio have traded over $4,222,376 worth of TELA Bio stock and bought 4,343,227 units worth $46,898,981 . The most active insiders traders include Management Inc. Opaleye, Investments, Lpwong Roderic... und Advisors Llc Orbi Med Capit.... On average, TELA Bio executives and independent directors trade stock every 18 days with the average trade being worth of $139,070. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 28 June 2024, trading 428,300 units of TELA stock currently worth $2,021,576.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio executives and other stock owners filed with the SEC include: